A federal jury in Boston convicted ex-CEO Kapoor and his co-defendants after 15 days of deliberation, Reuters reported. Prosecutors charged that Kapoor oversaw a scheme to bribe doctors by retaining them to act as speakers at sham events at restaurants ostensibly meant to educate clinicians about the company's fentanyl spray, Subsys. While Subsys was approved in 2012 only for use in treating severe pain in cancer patients, prosecutors claimed doctors who took bribes often prescribed Subsys to patients without cancer, helping boost sales for Insys.